Zylox-Tonbridge Medical repurchases 60,000 H shares, lifting treasury stock to 11.12 million

Bulletin Express

Jun 11

Zylox-Tonbridge Medical Technology Co., Ltd. disclosed that it bought back 60,000 H shares on 11 June 2026 via on-market transactions at prices ranging from HKD 18.05 to HKD 18.91. The transaction cost totalled HKD 1.10 million.

Following the repurchase, the company’s outstanding share count (excluding treasury shares) fell by 0.018% to 325.23 million, while treasury shares increased to 11.12 million. The total issued share capital remained unchanged at 336.35 million shares.

The buyback forms part of a mandate approved on 13 May 2026, which authorises Zylox-Tonbridge Medical to repurchase up to 32.72 million shares. Including the latest transaction, cumulative repurchases under this mandate stand at 197,200 shares, equivalent to 0.59% of the issued share base on the mandate date.

In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 11 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1187005451"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187005451\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187005451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187005451","market":"hk","top_or_hot":-1,"title":"Zylox-Tonbridge Medical repurchases 60,000 H shares, lifting treasury stock to 11.12 million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. disclosed that it bought back 60,000 H shares on 11 June 2026 via on-market transactions at prices ranging from HKD 18.05 to HKD 18.91. The transaction cost totalled HKD 1.10 million.</p>\n<p>Following the repurchase, the company’s outstanding share count (excluding treasury shares) fell by 0.018% to 325.23 million, while treasury shares increased to 11.12 million. The total issued share capital remained unchanged at 336.35 million shares.</p>\n<p>The buyback forms part of a mandate approved on 13 May 2026, which authorises Zylox-Tonbridge Medical to repurchase up to 32.72 million shares. Including the latest transaction, cumulative repurchases under this mandate stand at 197,200 shares, equivalent to 0.59% of the issued share base on the mandate date.</p>\n<p>In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 11 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Medical repurchases 60,000 H shares, lifting treasury stock to 11.12 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Medical repurchases 60,000 H shares, lifting treasury stock to 11.12 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. disclosed that it bought back 60,000 H shares on 11 June 2026 via on-market transactions at prices ranging from HKD 18.05 to HKD 18.91. The transaction cost totalled HKD 1.10 million.</p>\n<p>Following the repurchase, the company’s outstanding share count (excluding treasury shares) fell by 0.018% to 325.23 million, while treasury shares increased to 11.12 million. The total issued share capital remained unchanged at 336.35 million shares.</p>\n<p>The buyback forms part of a mandate approved on 13 May 2026, which authorises Zylox-Tonbridge Medical to repurchase up to 32.72 million shares. Including the latest transaction, cumulative repurchases under this mandate stand at 197,200 shares, equivalent to 0.59% of the issued share base on the mandate date.</p>\n<p>In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 11 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1187005451","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187005451","pubTimestamp":1781172131,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. disclosed that it bought back 60,000 H shares on 11 June 2026 via on-market transactions at prices ranging from HKD 18.05 to HKD 18.91. The transaction...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"归乐通桥医疗回购6万股H股库存股增至1112万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. disclosed that it bought back 60,000 H shares on 11 June 2026 via on-market transactions at prices ranging from HKD 18.05 to HKD 18.91. The transaction cost totalled HKD 1.10 million.\nFollowing the repurchase, the company’s outstanding share count (excluding treasury shares) fell by 0.018% to 325.23 million, while treasury shares increased to 11.12 million. The total issued share capital remained unchanged at 336.35 million shares.\nThe buyback forms part of a mandate approved on 13 May 2026, which authorises Zylox-Tonbridge Medical to repurchase up to 32.72 million shares. Including the latest transaction, cumulative repurchases under this mandate stand at 197,200 shares, equivalent to 0.59% of the issued share base on the mandate date.\nIn accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 11 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}